More GSK ghostwriting examples surface

On the heels of ghostwriting allegations involving GlaxoSmithKline and a book purportedly authored by two doctors, Talking Points Memo points out additional publications--this time in medical journals--allegedly ghosted by the same writer on behalf of GSK. The company has said that its internal guidelines governing medical writers have since been tightened up. Report

Suggested Articles

New real-world data from Lilly and BI show their SGLT2 med Jardiance topped GLP-1s at preventing heart failure hospitalization.

Following its headline-grabbing presentation at ESC, AZ is out with more data that support Farxiga use in nondiabetic heart failure patients.

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.